|
The planemaker's shares jumped about 6% in early trading after
the U.S. Federal Aviation Administration chief Steve Dickson
signed an order to allow the best-selling plane to resume
flights following two fatal crashes that led to Boeing's biggest
crisis in decades.
Meanwhile, Pfizer Inc said it would apply for emergency U.S.
authorization of its COVID-19 vaccine within days and disclosed
final results from a late-stage trial that showed it was 95%
effective. The company's shares rose 3%.
The announcement comes after Moderna Inc on Monday released
preliminary data for its COVID-19 vaccine, showing similar
effectiveness.
At 07:05 a.m. ET, Dow E-minis gained 0.45%, S&P 500 E-minis rose
0.3% and Nasdaq 100 E-minis were up 0.1%.
"Whilst it doesn't mean much for today (unlike last Monday), it
does underscore the fact that we are heading into a much
brighter 2021 and whilst temporary lockdowns need to be endured,
the back-to-normal trade is still 'on'," said Neil Wilson, chief
market analyst at Markets.com, referring to the muted market
reaction to Pfizer's update.
The benchmark S&P 500 and the blue-chip Dow retreated from
all-time highs on Tuesday as glum U.S. retail sales data, as
well as the specter of fresh restrictions dampened demand for
risky assets.
The number of reported global daily deaths from the coronavirus
stood at its highest ever on Tuesday, as the United States
entered winter.
Among other stocks, Target Corp rose 2.4% after the retailer
beat expectations for quarterly profit and sales, helped by its
quick delivery services.
Beyond Meat Inc gained 1.3% after the faux meat maker launched
plant-based minced pork in China.
(Reporting by Shivani Kumaresan and Sruthi Shankar in Bengaluru;
Additional reporting by Joice Alves in London; Editing by Sriraj
Kalluvila)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|
